Skip to content

Effect of Chandrakalarasa in excessive menstrual bleeding

Effect of Chandrakalarasa in Abnormal Uterine Bleeding due to Ovulatory Dysfunction - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079248
Enrollment
26
Registered
2025-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

None listed

Sponsors

Maya S Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women who are willing to give written consent among the age group of 18 to 45 years having the complaint of ovulatory dysfunction by excluding other structural and functional causes of AUB by USG abdomen and pelvis, prolonged bleeding that is for a period of more than 7 days and excessive menstrual bleeding for blood loss of more than 80 ml or changing more than 3 pads completely soaked per day for the past 3 menstrual cycle

Exclusion criteria

Exclusion criteria: Blood haemoglobin level less than 7gm percentage, pregnant and lactating mothers,vaginal bleeding due to inherited bleeding disorders,vaginal bleeding after menopause,bleeding in patients taking hormonal therapy,associated with IUCD or oral contraceptive pills,known case of systemic diseases like uncontrolled diabetic mellitus,hypertension,liver dysfunction

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of Chandrakala rasa in reducing the amount of bleeding in AUB O assessed by PBAC score and in reducing duration of bleedingTimepoint: after 3 consecutive menstrual cycle

Secondary

MeasureTime frame
to evaluate the effect of Chandrakala rasa on blood haemoglobin levelTimepoint: after 3 consecutive menstrual cycles

Countries

India

Contacts

Public ContactDr Shahina Mole S

Government Ayurveda College Tripunithura

shahinamoleabdulmajeed@gmail.com9495718796

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026